Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1200/JCO.23.00992 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Reply to the Letter to the Editor 'Circulating tumor DNA after definitive therapy for locally advanced rectal cancer' by Drs Sorscher and Rocha Lima.
Ann Oncol
December 2024
Department of Radiation Oncology, Colorectal and Anal Cancer Service, Memorial Sloan Kettering Cancer Center, New York, USA. Electronic address:
Reply to S. Sorscher.
J Clin Oncol
November 2024
James Hadfield, PhD, Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, United Kingdom; Chris Abbosh, MD, PhD, Cancer Biomarker Development, Oncology R&D, AstraZeneca, Cambridge, United Kingdom, Saga Diagnostics, Lund, Sweden; Darren Hodgson, PhD, Cancer Biomarker Development, Oncology R&D, AstraZeneca, Cambridge, United Kingdom; and Dan Stetson, MS, Translational Medicine, Oncology R&D, AstraZeneca, Waltham, MA.
Reply to S. Sorscher.
J Clin Oncol
September 2024
Julia Butt, PhD, Infections and Cancer Epidemiology Division, German Cancer Research Center (DKFZ), Heidelberg, Germany; and Meira Epplein, PhD, Departments of Population Health Sciences and Medicine, Duke University, and Cancer Risk, Detection, and Interception Program, Duke Cancer Institute, Durham, NC.
Reply to G.B. Mann et al and S. Sorscher.
J Clin Oncol
June 2024
Reshma Jagsi, MD, DPhil, Emory University, Atlanta, GA, University of Michigan, Ann Arbor, MI; Kent A. Griffith, MS, University of Michigan, Ann Arbor, MI; Eleanor E. Harris, MD, St Luke's University Health Network, Easton, PA; Jean L. Wright, MD, Johns Hopkins University, Baltimore, MD; Abram Recht, MD, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; Alphonse G. Taghian, MD, PhD, Massachusetts General Hospital, Harvard Medical School, Boston, MA; Lucille Lee, MD, Northwell, Lake Success, NY; Meena S. Moran, MD, Yale University, New Haven, CT; William Small Jr, MD, Loyola University Chicago, Maywood, IL; Candice Johnstone, MD, Medical College of Wisconsin, Milwaukee, WI; Asal Rahimi, MD, University of Texas, Southwestern, Dallas, TX; Gary Freedman, MD, University of Pennsylvania, Philadelphia, PA; Mahvish Muzaffar, MD, East Carolina University, Greenville, NC; Bruce Haffty, MD, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Kathleen Horst, MD, Stanford University, Stanford, CA; Simon N. Powell, MD, PhD, Memorial Sloan-Kettering Cancer Center, New York, NY; Jody Sharp, BS, Michael Sabel, MD, and Anne Schott, MD, University of Michigan, Ann Arbor, MI; and Mahmoud El-Tamer, MD, Memorial Sloan-Kettering Cancer Center, New York, NY.
Reply to S. Sorscher.
J Clin Oncol
August 2023
Vivek Subbiah, MD, Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Medicine, Medical College of Wisconsin Cancer Center and Genome Sciences and Precision Medicine Center, Milwaukee, WI; and Razelle Kurzrock, MD, Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, WIN Consortium, Paris, France.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!